Oracle's remaining performance obligations have surged to $664 billion, yet the company's free cash flow remains deeply negative, a dynamic its chief financial officer declined to date for resolution. While the cloud division drives significant top-line growth, the capital intensity of building AI infrastructure is straining the balance sheet, leading to increased reliance on debt and equity issuance.
The stock trades at $131.14, a level that reflects a 52.08% decline over the past year. Shares sit well below the 52-week high of $283.40 and have fallen 31.85% year to date, lagging the S&P 500, which is up 12.78% over the same period. Oracle also trades below its 50-day moving average of $144.77 and its 200-day moving average of $159.87.
Cloud revenue now accounts for 60% of total company revenue, up from 48% a year ago. Within that segment, cloud infrastructure revenue grew 121% to reach $7.39 billion. Management reports GPU utilization at 97.9%, with renewed capacity being repriced at a 20% premium over prior contracts. Despite this growth, Oracle's free cash flow was negative $5.4 billion in the most recent quarter, following a fiscal 2026 total of negative $23.7 billion.
To fund its expansion, Oracle expects to spend between $90 billion and $95 billion on capital expenditures this year. Interest expense has risen 55% to $1.4 billion. After completing a $20 billion equity sale, the company plans to raise approximately $40 billion more through additional debt and equity offerings. The CFO stated that the company has not provided a specific timeframe for when free cash flow will turn positive.
Valuation metrics suggest the stock may be undervalued relative to peers. Oracle trades at roughly 16 times its non-GAAP earnings per share guide of $8.10 for the current fiscal year and about 12 times the consensus estimate of $10.9916 for next year. Its PEG ratio stands at 0.807. Over the past 30 days, analysts made 35 upward revisions and one downward revision to full-year EPS forecasts.
However, investors remain cautious about the funding requirements for this growth. Management expects about half of the remaining performance obligations to convert into sales over the next 36 months. For the upcoming quarter, Oracle guides for revenue growth of 30% to 34% and EPS between $1.85 and $1.93.
The market reaction to recent earnings highlights this tension. Despite beating estimates, Oracle shares ended the day down nearly 2%, giving up early gains. Analysts have made 23 downward revisions to the February-quarter EPS estimate in the last 30 days.
The average analyst price target is $237.36, based on input from 43 analysts, implying approximately 81% upside from current levels. This valuation assumes that operating margins will stabilize or expand as capacity scales and that financing costs do not continue to erode profitability.
A firm timeline for positive free cash flow or evidence of expanding operating margins would be required to shift the current risk assessment. Until those factors materialize, the low multiple reflects genuine balance sheet risks associated with high capital expenditure and dilution.